While New Orleans prepares for the excitement of the big game, it’s important to remember that sports injuries aren’t limited to the professionals. High school athletes, weekend warriors, and generall ...
Fintel on MSN7d
Truist Securities Upgrades Pacira BioSciences (PCRX)Fintel reports that on January 30, 2025, Truist Securities upgraded their outlook for Pacira BioSciences (NasdaqGS:PCRX) from ...
About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance ...
Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) ("Virpax" or the "Company"), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central ...
Accomplished Business and Financial Leader, Laura Brege, Appointed Chair ---- Paul J. Hastings and Andreas Wicki, PhD Retire from Board of ...
Two brothers have been jailed after stealing high-value cars and a bag of golf clubs. A police investigation was launched after two vehicles, an Audi A4 and an Audi Q7, were stolen from a driveway in ...
defendants created the false impression that Pacira had sufficient patent protections on Exparel (bupivacaine liposome injectable suspension), which the Company stated was critical to its future ...
Former surgeon carried out 'unsafe' and 'unsanitary' circumcisions as part of private mobile service
He was able to source the anaesthetic Bupivacaine Hydrochloride which is a prescription only medication. In 2015 Siddiqui was ‘struck off’ the General Medical Council Register after a panel of ...
Shares of Pacira BioSciences PCRX gained 11.1% on Friday after the company shared better-than-expected preliminary fourth-quarter 2024 sales figures for its marketed products. Additionally, the ...
Through his work as a clinical fellow in paediatric surgery at the University Hospital Southampton NHS Foundation Trust, he was able to source the anaesthetic Bupivacaine Hydrochloride.
Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced two key appointments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback